Transnasjonale forsker-initierte kliniske studier innenfor kardiovaskulære, autoimmune og metabolske sykdommer (Trials4Health 2026)

The scheme aims to "support and enable transnational collaboration between clinical research environments on investigator-initiated clinical studies" within cardiovascular, autoimmune, or metabolic diseases. Studies must be randomised and designed as pragmatic comparative effectiveness studies and/or investigating new uses of existing medicines.

Eligible applicants are "forskningsorganisasjon" (research organisations).

The call provides funding from the Norwegian component of EUR 1.2 million in total (EUR 0.9 million from Forskningsrådet; EUR 0.3 million from regional health enterprises via KLINBEFORSK). Per-project limits are "opp til 400 000 euro for prosjektdeltagere og opp til 500 000 euro for prosjektkoordinator" (up to EUR 400,000 for project participants and up to EUR 500,000 for project coordinators). Additional ECRIN support of up to 15% of budget may apply. The instrument is tilskudd (grant/subsidy).

The scheme uses a two-stage process: sketch submission deadline was 27 January 2026 at 00:00 CET; full proposal deadline is 17 June 2026 at 00:00 CEST. Applications are submitted through the ERA4Health portal at https://era4health.eu/calls/trials4health2026.php. The scheme is part of the "ERA4Health" programme. The page was last updated 14 November 2025.